BORGESON BLAKE sold 3.1% of their position (220K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $961.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/4/2025ACC: 0001856094-25-000006
Director
Since Apr 2021
-220K
Net shares
Net seller
$961.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
220K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−220K
Price / share
$4.37
Trade value
$961.40K
% of position
3.1%
12/2/2025
7.09M→6.87M
Total
Net shares
−220K
Net value
-$961.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/2/2025 | S · Sale | −220K | $4.37 | $961.40K | 3.1% | 7.09M | 6.87M |
| Total | −220K | -$961.40K | ||||||
Derivative Transactions0
No derivative transactions reported